Bibliotecas PUC-SP - Busca Integrada

Cancer Therapy Targeting CD47/SIRPα

per Nazli Dizman, Elizabeth I. Buchbinder
Publicat a Cancers (2021-12-01)

Complex inter-relationship of body mass index, gender and serum creatinine on survival: exploring the obesity paradox in melanoma patients treated with checkpoint inhibition

per Girish S. Naik, Sushrut S. Waikar, Alistair E. W. Johnson, Elizabeth I. Buchbinder, Rizwan Haq, F. Stephen Hodi, Jonathan D. Schoenfeld, Patrick A. Ott
Publicat a Journal for ImmunoTherapy of Cancer (2019-03-01)

A phase I trial of panobinostat (LBH589) in patients with metastatic melanoma

per Nageatte Ibrahim, Elizabeth I. Buchbinder, Scott R. Granter, Scott J. Rodig, Anita Giobbie‐Hurder, Carla Becerra, Argyro Tsiaras, Evisa Gjini, David E. Fisher, F. Stephen Hodi
Publicat a Cancer Medicine (2016-11-01)

753 An open-label, phase 1a/b study of AB248, a CD8+ selective IL-2 mutein fusion protein, alone or in combination with pembrolizumab in patients with advanced solid tumors

per Costantine Albany, Andrea Pirzkall, Michael Chisamore, Jennifer Visich, Elizabeth I Buchbinder, Xiaohan Liu, David R Spigel, Kelly D Moynihan, Christopher DelNagro, Matt Axt, Mark Sayles
Publicat a Journal for ImmunoTherapy of Cancer (2023-11-01)

A deep molecular response of splenic marginal zone lymphoma to front-line checkpoint blockade

per Peter G. Miller, Adam S. Sperling, Christopher J. Gibson, Olga Pozdnyakova, Waihay J. Wong, Michael P. Manos, Elizabeth I. Buchbinder, F. Stephen Hodi, Benjamin L. Ebert, Matthew S. Davids
Publicat a Haematologica (2020-09-01)

Nivolumab maintenance improves overall survival of patients with advanced melanoma who experience severe immune-related adverse events on nivolumab plus ipilimumab

per David Liu, F Stephen Hodi, Rizwan Haq, Anita Giobbie-Hurder, Ann W Silk, Patrick A Ott, Tamara A Sussman, Elizabeth I Buchbinder, Anna K Maloney, Nikita Katukota, Miklos C Fogarasi, Megan Insco
Publicat a Journal for ImmunoTherapy of Cancer (2024-08-01)

Topical imiquimod and cryotherapy in combination with systemic immunotherapy in unresectable stage IIIC melanoma

per Jennifer E. Yeh, MD, PhD, Marilyn T. Wan, MBChB, MPH, Allireza Alloo, MD, Nageatte Ibrahim, MD, Patrick A. Ott, MD, PhD, Elizabeth I. Buchbinder, MD, Jennifer Y. Lin, MD
Publicat a JAAD Case Reports (2022-09-01)

Combining CTLA-4 and angiopoietin-2 blockade in patients with advanced melanoma: a phase I trial

per Mariano Severgnini, Rizwan Haq, Anita Giobbie-Hurder, Scott J Rodig, Patrick A Ott, Evisa Gjini, Ryan J Sullivan, Donald P Lawrence, Matthew Nazzaro, Kathleen L Pfaff, Jacquelyn O Wolff, Elizabeth I Buchbinder
Publicat a Journal for ImmunoTherapy of Cancer (2021-11-01)

578 Anti-PD-1 therapy alters the generation and durability of de novo responses to vaccination in humans

per Michael Manos, Arlene Sharpe, F Stephen Hodi, Joanna Baginska, Elizabeth I Buchbinder, Marta Holovatska, Kelly P Burke, Taras M Chicz, Julia Huezo, Duck Kyun Yoo, Fnu Keerti, Caihong Bi, Ryan McNamara, Duane Wesemann
Publicat a Journal for ImmunoTherapy of Cancer (2023-11-01)

Characterization of genetics in patients with mucosal melanoma treated with immune checkpoint blockade

per Elizabeth I. Buchbinder, Jason L. Weirather, Michael Manos, Brian J. Quattrochi, Lynette M. Sholl, Ryan C. Brennick, Peter Bowling, Nancy Bailey, Lisa Magarace, Patrick A. Ott, Rizwan Haq, Benjamin Izar, Anita Giobbie‐Hurder, F. Stephen Hodi
Publicat a Cancer Medicine (2021-04-01)

Observational study of talimogene laherparepvec use in the anti-PD-1 era for melanoma in the US (COSMUS-2)

per James Sun, Brian R Gastman, Lucy McCahon, Elizabeth I Buchbinder, Igor Puzanov, Michele Nanni, James M Lewis, Richard D Carvajal, Shahnaz Singh-Kandah, Anupam M Desai, Leon Raskin, Carrie M Nielson, Rubina Ismail, Jonathan S Zager
Publicat a Melanoma Management (2020-07-01)

Therapy with high-dose Interleukin-2 (HD IL-2) in metastatic melanoma and renal cell carcinoma following PD1 or PDL1 inhibition

per Elizabeth I. Buchbinder, Janice P. Dutcher, Gregory A. Daniels, Brendan D. Curti, Sapna P. Patel, Shernan G. Holtan, Gerald P. Miletello, Mayer N. Fishman, Rene Gonzalez, Joseph I. Clark, John M. Richart, Christopher D. Lao, Scott S. Tykodi, Ann W. Silk, David F. McDermott
Publicat a Journal for ImmunoTherapy of Cancer (2019-02-01)

A retrospective analysis of High-Dose Interleukin-2 (HD IL-2) following Ipilimumab in metastatic melanoma

per Sandra Aung, Sigrun Hallmeyer, David F. McDermott, Joseph I. Clark, Howard L. Kaufman, Gregory A. Daniels, Sapna P. Patel, John M. Kirkwood, Ryan J. Sullivan, Marc S. Ernstoff, Brendan D. Curti, Elizabeth I. Buchbinder, Rene Gonzalez, John M. Richart, Anasuya Gunturi, Jessica Perritt, Janice Dutcher, Girald P. Miletello, Joe Lutzky, Michael A. Morse
Publicat a Journal for ImmunoTherapy of Cancer (2016-11-01)

Specific oncogene activation of the cell of origin in mucosal melanoma

per Swathy Babu, Jiajia Chen, Chloé S. Baron, Kaiwen Sun, Emily Robitschek, Alicia M. McConnell, Constance Wu, Aikaterini Dedeilia, Moshe Sade-Feldman, Rodsy Modhurima, Michael P. Manos, Kevin Y. Chen, Anna M. Cox, Calvin G. Ludwig, Manolis Kellis, Elizabeth I. Buchbinder, Nir Hacohen, Jiekun Yang, Genevieve M. Boland, Brian J. Abraham, David Liu, Leonard I. Zon, Megan L. Insco
Publicat a Nature Communications (2025-07-01)

Proceedings of the seventh annual Women in Melanoma Conference

per Yana G. Najjar, Marlana Orloff, Tara C. Mitchell, Tawnya L. Bowles, Allison Betof Warner, Kathryn Bollin, Sunandana Chandra, Justine V. Cohen, Zeynep Eroglu, Pauline Funchain, Elizabeth Gaughan, Isabella Glitza Oliva, Sherry Hsu, Siwen Hu-Lieskovan, Lucy Boyce Kennedy, Thach-Giao Truong, Meredith McKean, Janice Mehnert, Helen Moon, Katy K. Tsai, Melissa Wilson, Thuy Tran, Elizabeth I. Buchbinder, Leslie A. Fecher, Samantha Guild, Sapna P. Patel
Publicat a Therapeutic Advances in Medical Oncology (2025-06-01)

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma, version 3.0

per Omid Hamid, Diwakar Davar, Keisuke Shirai, Benjamin Izar, Charlotte E Ariyan, Michael K Wong, Jason J Luke, Janis M Taube, Anna C Pavlick, Meghan J Mooradian, Douglas B Johnson, Hussein A Tawbi, Tara C Mitchell, Ryan J Sullivan, April KS Salama, Krista M Rubin, Elizabeth I Buchbinder, Sarah A Weiss, Tina J Hieken, Geoffrey T Gibney, Rajan P Kulkarni, J Keith Tolley, Caressa Valdueza
Publicat a Journal for ImmunoTherapy of Cancer (2023-10-01)

Advanced stage melanoma during pregnancy: recommendations from a retrospective, multicentre, registry-based studyResearch in context

per Jessica S.W. Borgers, Douglas B. Johnson, Elisabeth Livingstone, Dirk Schadendorf, Elizabeth I. Buchbinder, Lauren E. Haydu, Laura Gohil, William A. Robinson, Inderjit Mehmi, Omid Hamid, Michelle Ferreira, April K.S. Salama, Florentia Dimitriou, Matteo S. Carlino, Georgina V. Long, Paolo A. Ascierto, Ester Simeone, Yana G. Najjar, Geke A.P. Hospers, Jacob Choi, Sunandana Chandra, Jeffrey D. Wayne, Carlos I.R. García, Wen Xu, Céleste Lebbé, Laetitia Da-Meda, Victoria Atkinson, Meredith Mckean, Andrea Forschner, Elliot A. Asare, Antonios Daletzakis, Jolyn S. Taylor, Frédéric Amant, Katy K. Tsai, Zeynep Eroglu, John B.A.G. Haanen, Isabella C. Glitza de Oliva
Publicat a EClinicalMedicine (2025-11-01)